Gamma-hydroxybutyric acid affects the acquisition and reinstatement of cocaine-induced conditioned place preference in mice

Behavioural Pharmacology

Volumn 17, Issue 2, 2006, Pages 119-131

  Maldonado, Concepción ^a   Rodríguez Arias, Marta ^a   Castillo, Ana ^a   Aguilar, María A ^a   Miñarro, José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

hydroxybutyric acid; Cocaine; Conditioned place preference; Mouse; Reinstatement

Indexed keywords

4 HYDROXYBUTYRIC ACID; COCAINE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; EVALUATION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; REWARD;

ANESTHETICS, INTRAVENOUS; ANIMALS; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; MALE; MICE; MOTOR ACTIVITY; SODIUM OXYBATE;

EID: 33644585308     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000190685.84984.ec     Document Type: Article

References (50)

1. Addolorato G, Cibin M, Caputo F, Capristo E, Gessa GL, Stefanini GF, Gasbarrini G (1998). Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients. Drug Alcohol Depend 53:7-10.
2. Bellis MA, Hughes K, Bennett A, Thomson R (2003). The role of an international nightlife resort in the proliferation of recreational drugs. Addiction 98:1713-1721.
3. Brabant C, Quertemont E, Tirelli E (2005). Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL/6J mice. Psychopharmacology 180:33-40.
4. Broughton R, Mamelak M (1979). The treatment of narcolepsy-catalepsy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 6:1-6.
5. Campbell J, Nickel EJ, Penick EC, Wallace D, Gabrielli WF, Rowe C, et al. (2003). Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients. Am J Addict 12:122-136.
6. Cervo L, Samanin R (1995). Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673:242-250.
7. Cheramy A, Nieoullon A, Glowinski J (1977). Stimulating effects of γ-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat. J Pharmac Exp Ther 202:283-293.
8. Cunningham CL, Dickinson SD, Grahame NJ, Okorn DM, McMullin CS (1999). Genetic differences in cocaine-induced conditioned place preference in mice depend on conditioning trial duration. Psychopharmacology 146:73-80.
9. Di Chiara G (2002). Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 137:75-114.
10. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
11. Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa GL (1991). Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res 566:208-211.
12. Fadda P, Scherma M, Fresu A, Collu M, Fratta W (2003). Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 50:1-6.
13. Fattore L, Martellotta MC, Cossu G, Fratta W (2000). Gamma-hydroxybutyric acid: an evaluation of its rewarding properties in rats and mice. Alcohol 20:247-256.
14. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Gerrara SD, et al. (1989). Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2:787-789.
15. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL (1992). Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res 16:673-676.
16. Gallimberti L, Cibin M, Pagnin P, Sabbion R, Pani PP, Pirastu R, et al. (1993). Gamma-hydroxybutyric acid for treatment of opioid withdrawal syndrome. Neuropsychopharmacology 9:77-81.
17. Gallimberti L, Schifano F, Forza G, Miconi L, Ferrara SD (1994). Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiatry Clin Neurosci 244:113-114.
18. Gallimberti L, Spella MR, Soncini CA, Gessa GL (2000). Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20:257-262.
19. Hechler V, Gobaille S, Bourguignon J, Maitre M (1991). Extracellular events induced by γ-hydroxybutyrate in striatum: a microdialysis study. J Neurochem 56:938-944.
20. Hechler V, Gobaille S, Maitre M (1992). Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 572:345-348.
21. Howard SG, Feigenbaum JJ (1997). Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals. Biochem Pharmacol 53:103-110.
22. Hurd YL, Ungerstedt U (1989). Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 3:48-54.
23. Itzhak Y, Ali SF (2002). Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann NY Acad Sci 965:451-460.
24. Itzhak Y, Martin JL (2000). Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice. Psychopharmacology 152:216-223.
25. Itzhak Y, Martin JL (2002). Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants. Neuropsychopharmacology 26:130-134.
26. Koob GF (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
27. Kreek MJ, LaForge KS, Butelman E (2002). Pharmacotherapy of addictions. Nat Rev Drug Discov 1:710-726.
28. Liao RM, Chang YH, Wang SH (1998). Influence of SCH23390 and spiperone on the expression of conditioned place preference induced by D-amphetamine or cocaine in the rat. Chin J Physiol 41:85-92.
29. Maitre M (1997). The γ-hydroxybutytate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361.
30. Maldonado C, Rodriguez-Arias M, Aguilar MA, Minarro J (2004). GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice. Psychopharmacology 177:130-140.
31. Martellota MC, Balducci C, Fattore L, Cossu G, Gessa GL, Pulvirenti L, Fratta W (1998). Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 59:697-702.
32. Mueller D, Stewart J (2000). Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 115:39-47.
33. Nicholson KL, Balster RL (2001). GHB: a new and novel drug of abuse. Drug Alcohol Depend 63:1-22.
34. Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL (2005). Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABAB receptor-mediated effects. Neuroscience 131:465-474.
35. Raby WN, Coomaraswamy S (2004). Gabapentin reduces cocaine use among addicts from a community clinic sample. J Clin Psychiatry 65:84-86.
36. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2003). Reinstatement of morphine-induced conditioned place preference in mice by priming injections. Neural Plast 10:279-290.
37. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2005). NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference. Brain Res Bull 64:493-503.
38. Romieu P, Meunier J, Garcia D, Zozime N, Martin-Fardon R, Bowen WD, Maurice T (2004). The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharmacology 175:154-162.
39. Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA (2003). Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 119:497-505.
40. Schmidt-Mutter C, Gobaille S, Muller C, Maitre M (1999). Prodynorphin and proenkephalin mRNAs are increased in rat brain alters acute and chronic administration of gamma-hydroxybutyrate. Neurosci Lett 262:65-68.
41. Seale TW, Carney JM (1991). Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine. J Addict Dis 10:141-162.
42. Shoptaw S, Kintaudi PC, Charuvastra C, Ling W (2002). A screening trial of amantadine as a medication for cocaine dependence. Drug Alcohol Depend 66:217-224.
43. Sircar R, Basak A (2004). Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning. Pharmacol Biochem Behav 79:701-708.
44. Slattery DA, Markou A, Froestl W, Cryan JF (2005). The GABAB receptor-positive modulator GS39783 and the GABA(B) receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30:2065-2072.
45. Szumlinski KK, Price KL, Frys KA, Middaugh LD (2002). Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice. Behav Brain Res 136:151-160.
46. Tzschentke TM (1998). Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672.
47. Tzschentke TM, Schmidt WJ (1995). N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193:37-40.
48. Uchimura N, North RA (1991). Baclofen and adenosine inhibit synaptic potentials mediated by gamma-aminobutyric acid and glutamate release in rat nucleus accumbens. J Pharmacol Exp Ther 258:663-668.
49. van den Brink W, van Ree JM (2003). Pharmacological treatments for heroin and cocaine addiction. Eur Neuropsychopharmacol 13:476-487.
50. Zhang Y, Manisch JR, Schlussman SD, Ho A, Kreek MJ (2002). Conditioned place preference after single doses or 'binge' cocaine in C57BL/6J and 129/J mice. Pharmacol Biochem Behav 73:655-662.